Approaches to study posttranslational regulation of intermediate filament proteins

Methods in Cell Biology

Volumn 2004, Issue 78, 2004, Pages 373-409

  Kochin, Vitaly ^a   Pallari, Hanna Mari ^a   Pant, Harish ^b   Eriksson, John E ^a  

^a UNIVERSITY OF TURKU   (Finland)

^b NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYME INHIBITOR; INTERMEDIATE FILAMENT PROTEIN; NEUROFILAMENT PROTEIN; PEPTIDE FRAGMENT; PHOSPHOPROTEIN PHOSPHATASE; PROTEIN KINASE; PROTEIN KINASE INHIBITOR; TRYPSIN; VIMENTIN;

AMINO ACID SEQUENCE; ANIMAL; ARTICLE; BINDING SITE; CELL LINE; CHEMISTRY; DRUG ANTAGONISM; GENETIC TRANSFECTION; GENETICS; HAMSTER; HUMAN; IN VITRO STUDY; ISOLATION AND PURIFICATION; MASS SPECTROMETRY; METABOLISM; METHODOLOGY; MOLECULAR GENETICS; PHOSPHORYLATION; PROTEIN PROCESSING; SITE DIRECTED MUTAGENESIS;

AMINO ACID SEQUENCE; ANIMALS; BINDING SITES; CELL LINE; CRICETINAE; ENZYME INHIBITORS; HUMANS; INTERMEDIATE FILAMENT PROTEINS; MASS SPECTROMETRY; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; NEUROFILAMENT PROTEINS; PEPTIDE FRAGMENTS; PHOSPHOPROTEIN PHOSPHATASE; PHOSPHORYLATION; PROTEIN KINASE INHIBITORS; PROTEIN KINASES; PROTEIN PROCESSING, POST-TRANSLATIONAL; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TRANSFECTION; TRYPSIN; VIMENTIN;

EID: 14244263738     PISSN: 0091679X     EISSN: None     Source Type: Book Series    
DOI: 10.1016/s0091-679x(04)78014-0     Document Type: Review

References (105)

1. Adamczyk, M., Gebler, J. C., and Wu, J. (2001). Selective analysis of phosphopeptides within a protein mixture by chemical modification, reversible biotinylation and mass spectrometry. Rapid Commun. Mass Spectrom. 15, 1481-1488.
2. Akiyama, T., and Ogawara, H. (1991). Use and specificity of genistein as inhibitor of protein-tyrosine kinases. Methods Enzymol. 201, 362-370.
3. Alessi, F., Quarta, S., Savio, M., Riva, F., Rossi, L., Stivala, L. A., Scovassi, A. I., Meijer, L., and Prosperi, E. (1998). The cyclin-dependent kinase inhibitors olomoucine and roscovitine arrest human fibroblasts in G1 phase by specific inhibition of CDK2 kinase activity. Exp. Cell Res. 245, 8-18.
4. Angelastro, J. M., Ho, C. L., Frappier, T., Liem, R. K., and Greene, L. A. (1998). Peripherin is tyrosine-phosphorylated at its carboxyl-terminal tyrosine. J. Neurochem. 70, 540-549.
5. Annan, R. S., and Carr, S. A. (1996). Phosphopeptide analysis by matrix-assisted laser desorption time-of-flight mass spectrometry. Anal. Chem. 68, 3413-3421.
6. Asara, J. M., and Allison, J. (1999). Enhanced detection of phosphopeptides in matrix-assisted laser desorption/ionization mass spectrometry using ammonium salts. J. Am. Soc. Mass. Spectrom. 10, 35-44.
7. Badger, A. M., Bradbeer, J. N., Votta, B., Lee, J. C., Adams, J. L., and Griswold, D. E. (1996). Pharmacological profile of SB 203580, a selective inhibitor of cytokine suppressive binding protein/p38 kinase, in animal models of arthritis, bone resorption, endotoxin shock and immune function. J. Pharmacol. Exp. Ther. 279, 1453-1461.
8. Bennett, K. L., Stensballe, A., Podtelejnikov, A. V., Moniatte, M., and Jensen, O. N. (2002). Phosphopeptide detection and sequencing by matrix-assisted laser desorption/ionization quadrupole time-of-flight tandem mass spectrometry. J. Mass. Spectrom. 37, 179-190.
9. Bhat, S. V. (1993). Forskolin and congeners. Fortschr. Chem. Org. Naturst. 62, 1-74.
10. Bogoyevitch, M. A., Boehm, I., Oakley, A., Ketterman, A. J., and Barr, R. K. (2004). Targeting the JNK. MAPK cascade for inhibition: Basic science and therapeutic potential. Biochim. Biophys. Acta 1697, 89-101.
11. Boyle, W. J., van der Geer P., and Hunter T. (1991). Phosphopeptide mapping and phosphoamino acid analysis by two-dimensional separation on thin-layer cellulose plates. Methods Enzymol. 201, 110-149.
12. Carden, M. J., Schlaepfer, W. W., and Lee, V. M. (1985). The structure, biochemical properties, and immunogenicity of Neurofilament peripheral regions are determined by phosphorylation state. J. Biol. Chem. 260, 9805-9817.
13. Chou, C. F., and Omary, M. B. (1994). Mitotic arrest with anti-microtubule agents or okadaic acid is associated with increased glycoprotein terminal GlcNAc's. J. Cell Sci. 107(Pt 7), 1833-1843.
14. Cohen, P. (1989). The structure and regulation of protein phosphatases. Annu. Rev. Biochem. 58, 453-508.
15. Cohen, P., Holmes, C. F., and Tsukitani, Y. (1990). Okadaic acid: A new probe for the study of cellular regulation. Trends Biochem. Sci. 15, 98-102.
16. Coligan, J. E., Dunn, B. M., Ploegh, H. L., Speicher, D. W., and Wingfield, P. T. (1995). "Current Protocols in Protein Science." John Wiley & Sons Inc., New York.
17. Coulombe, P. A., and Omary, M. B. (2002). 'Hard' and 'soft' principles defining the structure, function and regulation of keratin intermediate filaments. Curr. Opin. Cell Biol. 14, 10-22.
18. Djordjevic, S., and Driscoll, P. C. (2002). Structural insight into substrate specificity and regulatory mechanisms of phosphoinositide 3-kinases. Trends Biochem. Sci. 27, 426-432.
19. Dudley, D. T., Pang, L., Decker, S. J., Bridges, A. J., and Saltiel, A. R. (1995). A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc. Natl. Acad. Sci. USA 92, 7686-7689.
20. Dumont, F. J., Staruch, M. J., Koprak, S. L., Melino, M. R., and Sigal, N. H. (1990). Distinct mechanisms of suppression of murine T cell activation by the related macrolides FK-506 and rapamycin. J. Immunol. 144, 251-258.
21. Eriksson, J. E., He, T., Trejo-Skalli, A. V., Harmala-Brasken, A. S., Hellman, J., Chou, Y. H., and Goldman, R. D. (2004). Specific in vivo phosphorylation sites determine the assembly dynamics of vimentin intermediate filaments. J. Cell Sci. 117, 919-932.
22. Eriksson, J. E., Opal, P., and Goldman, R. D. (1992). Intermediate filament dynamics. Curr. Opin. Cell Biol. 4, 99-104.
23. Eriksson, J. E., Toivola, D., Meriluoto, J. A., Karaki, H., Han, Y. G., and Hartshorne, D. (1990). Hepatocyte deformation induced by cyanobacterial toxins reflects inhibition of protein phosphatases. Biochem. Biophys. Res. Commun. 173, 1347-1353.
24. Eriksson, J. E., Toivola, D. M., Sahlgren, C., Mikhailov, A., and Harmala-Brasken, A. S. (1998). Strategies to assess phosphoprotein phosphatase and protein kinase-mediated regulation of the cytoskeleton. Methods Enzymol. 298, 542-569.
25. Falick, A. M. (1995). Matrix-assisted laser desorption ionization-time of flight (MALDI-TOF) analysis of peptides using post-source decay. In "PerSeptive Biosystems Technical Bulletin." PerSeptive Biosystems, Foster City, CA.
26. Fantes, P., and Brooks, R. (1993). "The Cell Cycle, A Practical Approach." IRL Press, Oxford.
27. Feng, L., Zhou, X., Liao, J., and Omary, M. B. (1999). Pervanadate-mediated tyrosine phosphorylation of keratins 8 and 19 via a p38 mitogen-activated protein kinase-dependent pathway. J. Cell Sci. 112(Pt 13), 2081-2090.
28. Fujiki, H., and Suganuma, M. (1993). Tumor promotion by inhibitors of protein phosphatases 1 and 2A: the okadaic acid class of compounds. Adv. Cancer Res. 61, 43-94.
29. Galli, C., Meucci, O., Scorziello, A., Werge, T. M., Calissano, P., and Schettini, G. (1995). Apoptosis in cerebellar granule cells is blocked by high KCl, forskolin, and IGF-1 through distinct mechanisms of action: The involvement of intracellular calcium and RNA synthesis. J. Neurosci. 15, 1172-1179.
30. Garrison, J. C. (1993). In "Protein Phosphorylation, A Practical Approach" (D. G. Hardie, ed.). Oxford University Press, Inc., New York.
31. Gjertsen, B. T., Mellgren, G., Otten, A., Maronde, E., Genieser, H. G., Jastorff, B., Vintermyr, O. K., McKnight, G. S., and Doskeland, S. O. (1995). Novel (Rp)-cAMPS analogs as tools for inhibition of cAMP-kinase in cell culture. Basal cAMP-kinase activity modulates interleukin-1 beta action. J. Biol. Chem. 270, 20599-20607.
32. Gordon, J. A. (1991). Use of vanadate as protein-phosphotyrosine phosphatase inhibitor. Methods Enzymol. 201, 110-149.
33. Grider, J. R. (1993). Interplay of VIP and nitric oxide in regulation of the descending relaxation phase of peristalsis. Am. J. Physiol. 264, G334-G340.
34. Hardie, D. G. (1993). "Protein Phosphorylation, A Practical Approach." Oxford University Press Inc, New York.
35. Hardie, D. G., Haystead, T. A., and Sim, A. T. (1991). Use of okadaic acid to inhibit protein phosphatases in intact cells. Methods Enzymol. 201, 469-476.
36. Harlow, E., and Lane, D. (1988). "Antibodies-A Laboratory Manual." Cold Spring Harbour Laboratory, New York.
37. Hei, Y. J., MacDonell, K. L., McNeill, J. H., and Diamond, J. (1991). Lack of correlation between activation of cyclic AMP-dependent protein kinase and inhibition of contraction of rat vas deferens by cyclic AMP analogs. Mol. Pharmacol. 39, 233-238.
38. Helfand, B. T., Chang, L., and Goldman, R. D. (2003). The dynamic and motile properties of intermediate filaments. Annu. Rev. Cell Dev. Biol. 19, 445-467.
39. Helfand, B. T., Chang, L., and Goldman, R. D. (2004). Intermediate filaments are dynamic and motile elements of cellular architecture. J. Cell Sci. 117, 133-141.
40. Hidaka, H., and Kobayashi, R. (1993). In "Protein Phosphorylation a Practical Approach" (D. G. Hardie, ed.). IRL Press, Oxford, England.
41. Hidaka, H., Watanabe, M., and Kobayashi, R. (1991): Properties and use of H-series compounds as protein kinase inhibitors. Methods Enzymol. 201, 328-339.
42. Honkanen, R. E., Codispoti, B. A., Tse, K., Boynton, A. L., and Honkanan, R. E. (1994). Characterization of natural toxins with inhibitory activity against serine/threonine protein phosphatases. Toxicon 32, 339-350.
43. Humphries, M. J. (1996). Integrin activation: The link between ligand binding and signal transduction. Curr. Opin. Cell Biol. 8, 632-640.
44. Hunter, T., and Sefton, B. M. (1991). "Methods in Enzymology." 201 (whole volume). Academic Press, New York.
45. Ishihara, H., Martin, B. L., Brautigan, D. L., Karaki, H., Ozaki, H., Kato, Y., Fusetani, N., Watabe, S., Hashimoto, K., Uemura, D., et al. (1989). Calyculin A and okadaic acid: Inhibitors of protein phosphatase activity. Biochem. Biophys. Res. Commun. 159, 871-877.
46. Jaffe, H., Veeranna, Shetty, K. T., and Pant, H. C. (1998). Characterization of the phosphorylation sites of human high molecular weight neurofilament protein by electrospray ionization tandem mass spectrometry and database searching. Biochemistry 37, 3931-3940.
47. Janek, K., Wenschuh, H., Dienert, M., and Krause, E. (2001). Phosphopeptide analysis by positive and negative ion matrix assisted laser desorption/ionization mass spectrometry. Rapid Commun. Mass Spectrom. 15, 1593-1599.
48. Kase, H., Iwahashi, K., Nakanishi, S., Matsuda, Y., Yamada, K., Takahashi, M., Murakata, C., Sato, A., and Kaneko, M. (1987). K-252 compounds, novel and potent inhibitors of protein kinase C and cyclic nucleotide-dependent protein kinases. Biochem. Biophys. Res. Commun. 142, 436-440.
49. Kaufmann, R., Chaurand, P., Kirsch, D., and Spengler, B. (1996). Post-source decay and delayed extraction in matrix-assisted laser desorption/ionization-reflectron time-of-flight mass spectrometry. Are there trade-offs? Rapid Commun. Mass Spectrom 10, 1199-1208.
50. Kinter, M., and Sherman, N. (2000). "Protein Sequencing and Identification Using Tandem Mass Spectrometry." John Wiley & Sons Inc., New York.
51. Kiss, Z., Phillips, H., and Anderson, W. H. (1995). The bisindolylmaleimide GF 109203X, a selective inhibitor of protein kinase C, does not inhibit the potentiating effect of phorbol ester on ethanol-induced phospholipase C-mediated hydrolysis of phosphatidylethanolamine. Biochim. Biophys. Acta 1265, 93-95.
52. Knight, Z. A., Schilling, B., Row, R. H., Kenski, D. M., Gibson, B. W., and Shokat, K. M. (2003). Phosphospecific proteolysis for mapping sites of protein phosphorylation. Nat. Biotechnol. 21, 1047-1054.
53. Kobayashi, E., Nakano, H., Morimoto, M., and Tamaoki, T. (1989). Calphostin C (UCN-1028C), a novel microbial compound, is a highly potent and specific inhibitor of protein kinase C. Biochem. Biophys. Res. Commun. 159, 548-553.
54. Ku, N. O., Liao, J., Chou, C. F., and Omary, M. B. (1996). Implications of intermediate filament protein phosphorylation. Cancer Metastasis Rev. 15, 429-444.
55. Ku, N. O., Liao, J., and Omary, M. B. (1998). Phosphorylation of human keratin 18 serine 33 regulates binding to 14-3-3 proteins. EMBO J. 17, 1892-1906.
56. Ku, N. O., Michie, S., Oshima, R. G., and Omary, M. B. (1995). Chronic hepatitis, hepatocyte fragility, and increased soluble phosphoglycokeratins in transgenic mice expressing a keratin 18 conserved arginine mutant. J. Cell Biol. 131, 303-314.
57. Ku, N. O., and Omary, M. B. (1995). Identification and mutational analysis of the glycosylation sites of human keratin 18. J. Biol. Chem. 270, 11820-11827.
58. Ku, N. O., and Omary, M. B. (2000). Keratins turn over by ubiquitination in a phosphorylation-modulated fashion. J. Cell Biol. 149, 547-552.
59. Levitzki, A., Gazit, A., Osherov, N., Posner, I., and Gilon, C. (1991). Inhibition of protein-tyrosine kinases by tyrphostins. Methods Enzymol. 201, 347-361.
60. Li, Y. M., and Casida, J. E. (1992). Cantharidin-binding protein: Identification as protein phosphatase 2A. Proc. Natl. Acad. Sci. USA 89, 11867-11870.
61. Liao, J., Ku, N. O., and Omary, M. B. (1997). Stress, apoptosis, and mitosis induce phosphorylation of human keratin 8 at Ser-73 in tissues and cultured cells. J. Biol. Chem. 272, 7565-7573.
62. Liao, J., and Omary, M. B. (1996). 14-3-3 proteins associate with phosphorylated simple epithelial keratins during cell cycle progression and act as a solubility cofactor. J. Cell Biol. 133, 345-357.
63. Liao, P. C., Leykam, J., Andrews, P. C., Gage, D. A., and Allison, J. (1994). An approach to locate phosphorylation sites in a phosphoprotein: Mass mapping by combining specific enzymatic degradation with matrix-assisted laser desorption/ionization mass spectrometry. Anal. Biochem. 219, 9-20.
64. Liu, J., Farmer, J. D., Jr., Lane, W. S., Friedman, J., Weissman, I., and Schreiber, S. L. (1991). Calcineurin is a common target of cyclophilin- cyclosporin A and FKBP-FK506 complexes. Cell 66, 807-815.
65. Loboda, A. V., Krutchinsky, A. N., Bromirski, M., Ens, W., and Standing, K. G. (2000). A tandem quadrupole/time-of-flight mass spectrometer with a matrix-assisted laser desorption/ionization source: design and performance. Rapid Commun. Mass. Spectrom. 14, 1047-1057.
66. MacKintosh, C. (1993). In "Protein Phosphorylation, A Practical Approach" (D. G. Hardie, ed.), pp. 197-210. Oxford University Press, Inc., New York.
67. MacKintosh, C., and MacKintosh, R. W. (1994). Inhibitors of protein kinases and phosphatases. Trends Biochem. Sci. 19, 444-448.
68. Mann, M., Hendrickson, R. C., and Pandey, A. (2001). Analysis of proteins and proteomes by mass spcctrometry. Annu. Rev. Biochem. 70, 437-473.
69. Mann, M., Ong, S. E., Gronborg, M., Steen, H., Jensen, O. N., and Pandey, A. (2002). Analysis of protein phosphorylation using mass spectrometry: Deciphering the phosphoproteome. Trends Biotechnol. 20, 261-268.
70. Marin, P., Nastiuk, K. L., Daniel, N., Girault, J. A., Czernik, A. J., Glowinski, J., Nairn, A. C., and Premont, J. (1997). Glutamate-dependent phosphorylation of elongation factor-2 and inhibition of protein synthesis in neurons. J. Neurosci. 17, 3445-3454.
71. Matsushima, R., Yoshizawa, S., Watanabe, M. F., Harada, K., Furusawa, M., Carmichael, W. W., and Fujiki, H. (1990). In Vitro and in vivo effects of protein phosphatase inhibitors, microcystins and nodularin, on mouse skin and fibroblasts. Biochem. Biophys. Res. Commun. 171, 867-874.
72. McLachlin, D. T., and Chait, B. T. (2001). Analysis of phosphorylated proteins and peptides by mass spectrometry. Curr. Opin. Chem. Biol. 5, 591-602.
73. Meijer, L., and Raymond, E. (2003). Roscovitine and other purines as kinase inhibitors. From starfish oocytes to clinical trials. Acc. Chem. Res. 36, 417-425.
74. Mokhtari, A., Do, Khac, L., Tanfin, Z., and Harbon, S. (1985). Forskolin modulates cyclic AMP generation in the rat myometrium. Interactions with isoproterenol and prostaglandins E2 and I2. J. Cyclic Nucleotide Protein Phosphor. Res. 10, 213-227.
75. Muid, R. E., Dale, M. M., Davis, P. D., Elliott, L. H., Hill, C. H., Kumar, H., Lawton, G., Twomey, B. M., Wadsworth, J., Wilkinson, S. E., et al. (1991). A novel conformationally restricted protein kinase C inhibitor, Ro 31-8425, inhibits human neutrophil superoxide generation by soluble, paniculate and post-receptor stimuli. FEBS Lett. 293, 169-172.
76. Neubauer, G., and Mann, M. (1999). Mapping of phosphorylation sites of gel-isolated proteins by nanoelectrospray tandem mass spectrometry: Potentials and limitations. Anal. Chem. 71, 235-242.
77. Nishino, H., Kitagawa, K., Iwashima, A., Ito, M., Tanaka, T., and Hidaka, H. (1986). N-(6-phenylhexyl)-5-chloro-1-naphthalenesulfonamide is one of a new class of activators for Ca2+-activated, phospholipid-dependent protein kinase. Biochim. Biophys. Acta 889, 236-239.
78. Nishio, H., Ikegami, Y., Segawa, T., and Nakata, Y. (1994). Stimulation of calcium sequestration by mezerein, a protein kinase C activator, in saponized rabbit platelets. Gen. Pharmacol. 25, 413-416.
79. Nishizawa, K., Yano, T., Shibata, M., Ando, S., Saga, S., Takahashi, T., and Inagaki, M. (1991). Specific localization of phosphointermediate filament protein in the constricted area of dividing cells. J. Biol. Chem. 266, 3074-3079.
80. Nuwaysir, L. M., and Stults, J. T. (1993). Electrospray ionization mass spectrometry of phosphopeptides isolated by on-line immobilized metal-ion affinity chromatography. J. Am. Soc. Mass Spectrom. 4, 662-669.
81. Oda, Y., Nagasu, T., and Chait, B. T. (2001). Enrichment analysis of phosphorylated proteins as a tool for probing the phosphoproteome. Nat. Biotechnol. 19, 379-382.
82. Ogawara, M., Inagaki, N., Tsujimura, K., Takai, Y., Sekimata, M., Ha, M. H., Imajoh-Ohmi, S., Hirai, S., Ohno, S., Sugiura, H., et al. (1995). Differential targeting of protein kinase C and CaM kinase II signalings to vimentin. J. Cell Biol. 131, 1055-1066.
83. Roivainen, R., and Messing, R. O. (1993). The phorbol derivatives thymeleatoxin and 12-deoxyphorbol-13-O-phenylacetate-10-acetate cause translocation and down-regulation of multiple protein kinase C isozymes. FEBS Lett. 319, 31-34.
84. Sahlgren, C. M., Mikhailov, A., Hellman, J., Chou, Y. H., Lendahl, U., Goldman, R. D., and Eriksson, J. E. (2001). Mitotic reorganization of the intermediate filament protein nestin involves phosphorylation by cdc2 kinase. J. Biol. Chem. 276, 16456-16463.
85. Sahlgren, C. M., Mikhailov, A., Vaittinen, S., Pallari, H. M., Kalimo, H., Pant, H. C., and Eriksson, J. E. (2003). Cdk5 regulates the organization of Nestin and its association with p35. Mol. Cell Biol. 23, 5090-5106.
86. Saitoh, M., Ishikawa, T., Matsushima, S., Naka, M., and Hidaka, H. (1987). Selective inhibition of catalytic activity of smooth muscle myosin light chain kinase. J. Biol. Chem. 262, 7796-7801.
87. Sambrook, J., and Russell, D. W. (2001). "Molecular Cloning-A Laboratory Manual," Vol. 3. Cold Spring Harbor Laboratory Press, New York.
88. Seamon, K. B., and Daly, J. W. (1981). Forskolin: A unique diterpene activator of cyclic AMP-generating systems. J. Cyclic Nucleotide Res. 7, 201-224.
89. Shetty, K. T., Link, W. T., and Pant, H. C. (1993). cdc2-like kinase from rat spinal cord specifically phosphorylates KSPXK motifs in neurofilament proteins: isolation and characterization. Proc. Natl. Acad. Sci. USA 90, 6844-6848.
90. Simon, H. U., Yousefi, S., Dibbert, B., Hebestreit, H., Weber, M., Branch, D. R., Blaser, K., Levi-Schaffer, F., and Anderson, G. P. (1998). Role for tyrosine phosphorylation and Lyn tyrosine kinase in fas receptor-mediated apoptosis in eosinophils. Blood 92, 547-557.
91. Spengler, B., Kirsch, D., Kaufmann, R., and Jaeger, E. (1992). Peptide sequencing by matrix-assisted laser-desorption mass spectrometry. Rapid Commun. Mass Spectrom. 6, 105-108.
92. Sumi, M., Kiuchi, K., Ishikawa, T., Ishii, A., Hagiwara, M., Nagatsu, T., and Hidaka, H. (1991). The newly synthesized selective Ca2+/calmodulin dependent protein kinase II inhibitor KN-93 reduces dopamine contents in PC12h cells. Biochem. Biophys. Res. Commun. 181, 968-975.
93. Takai, Y., Ogawara, M., Tomono, Y., Moritoh, C., Imajoh-Ohmi, S., Tsutsumi, O., Taketani, Y., and Inagaki, M. (1996). Mitosis-specific phosphorylation of vimentin by protein kinase C coupled with reorganization of intracellular membranes. J. Cell Biol. 133, 141-149.
94. Tamaoki, T. (1991). Use and specificity of staurosporine, UCN-01, and calphostin C as protein kinase inhibitors. Methods Enzymol. 201, 340-347.
95. Tepper, C. G., Jayadev, S., Liu, B., Bielawska, A., Wolff, R., Yonehara, S., Hannun, Y. A., and Seldin, M. F. (1995). Role for ceramide as an endogenous mediator of Fas-induced cytotoxicity. Proc. Natl. Acad. Sci. USA 92, 8443-8447.
96. Toivola, D. M., Goldman, R. D., Garrod, D. R., and Eriksson, J. E. (1997). Protein phosphatases maintain the organization and structural interactions of hepatic keratin intermediate filaments. J. Cell Sci. 110(Pt 1), 23-33.
97. Tokutake, S., Hutchison, S. B., Pachter, J. S., and Liem, R. K. (1983). A batchwise purification procedure of neurofilament proteins. Anal. Biochem. 135, 102-105.
98. Tsujimura, K., Ogawara, M., Takeuchi, Y., Imajoh-Ohmi, S., Ha, M. H., and Inagaki, M. (1994). Visualization and function of vimentin phosphorylation by cdc2 kinase during mitosis. J. Biol. Chem. 269, 31097-31106.
99. Ui, M., Okada, T., Hazeki, K., and Hazeki, O. (1995). Wortmannin as a unique probe for an intracellular signalling protein, phosphoinositide 3-kinase. Trends Biochem. Sci. 20, 303-307.
100. Umezawa, K., and Imoto, M. (1991). Use of erbstatin as protein-tyrosine kinase inhibitor. Methods Enzymol. 201, 379-385.
101. Valgeirsdottir, S., Claesson-Welsh, L., Bongcam-Rudloff, E., Hellman, U., Westermark, B., and Heldin, C. H. (1998). PDGF induces reorganization of vimentin filaments. J. Cell Sci. 111(Pt 14), 1973-1980.
102. Veeranna, K., Shetty, T., Link, W. T., Jaffe, H., Wang, J., and Pant, H. C. (1995). Neuronal cyclin-dependent kinase-5 phosphorylation sites in neurofilament protein (NF-H) are dephosphorylated by protein phosphatase 2A. J. Neurochem. 64, 2681-2690.
103. Villerbu, N., Gaben, A. M., Redeuilh, G., and Mester, J. (2002). Cellular effects of purvalanol A: A specific inhibitor of cyclin-dependent kinase activities. Int. J. Cancer 97, 761-769.
104. Zhang, X., Herring, C. J., Romano, P. R., Szczepanowska, J., Brzeska, H., Hinnebusch, A. G., and Qin, J. (1998). Identification of phosphorylation sites in proteins separated by polyacrylamide gel electrophoresis. Anal. Chem. 70, 2050-2059.
105. Zhou, W., Merrick, B. A., Khaledi, M. G., and Tomer, K. B. (2000). Detection and sequencing of phosphopeptides affinity bound to immobilized metal ion beads by matrix-assisted laser desorption/ionization mass spectrometry. J. Am. Soc. Mass Spectrom. 11, 273-282.